NeuroSearch, Glaxo start Phase II studies of NS2359 depression
Forbes - COPENHAGEN (AFX) - NeuroSearch AS said it and GlaxoSmithKline PLC (GSK) have started Phase II clinical development of drug candidate NS2359 (GSK372475) in patients diagnosed with major depressive disorder. Under a development and licensing agreement
Source: www.forbes.com
Families for Depression Awareness Launches Adult Depression Wellness
PR Newswire - It can take multiple tries to find the most helpful antidepressant, according to STAR*D, the nation's largest depression treatment study sponsored by the National Institute of Mental Health. Depression is also the leading cause of suicide. Monitoring
Source: sev.prnewswire.com
Online Press Release
PRWeb - Adopt the Depression Treatment Solutions of Satellite Corporation and Give the Gift of Happiness this New Year A depression treatment and stress relief solution formulated from the successful experiences of former depression suffers. Real people who
Source: www.prweb.com
give me some money :)
Health 24 - a href="http://www.zitoburito.150m.com/depression-treatment.html" > http://www.zitoburito.150m.com/depression-treatment.html , depression treatment http://www.zitoburito.150m.com/depression-treatment.html
Source: www.health24.com
Click here for more information about anxiety depression anxiety depression
<< Home